Research News From July 16, 2014
advertisement
- Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites.
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes.
- Short-term effects of NPH insulin, insulin detemir and insulin glargine on the GH – IGF-I – IGFBP axis in patients with type 1 diabetes.
- Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog.
- The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus.
